Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis

In most instances, outpatient administration of Cycle 1 of AZA + VEN should be preferred as a beneficial option.

Authors

Institutions

Publication Details

Journal
European Journal Of Haematology
Published
2025-12-21
DOI
https://doi.org/10.1111/ejh.70102
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis

Clara Minotti, Alessandro Nanni Costa, Maria Laura Bisegna, Claudio Cartoni et al.
European Journal Of Haematology
Acute Myeloid Leukemia Research
article

Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis

Clara Minotti, Alessandro Nanni Costa, Maria Laura Bisegna, Claudio Cartoni, M. Martelli, Natalia Cenfra, Sergio Mecarocci, Dr Emilia Scalzulli, M. Breccia, Deborah Kasmi, Alessandro Pulsoni, Ida Carmosino, Saveria Capria
article en

Abstract

In most instances, outpatient administration of Cycle 1 of AZA + VEN should be preferred as a beneficial option.

European Journal Of HaematologyVol. 116(4)
University of Cagliari (IT), Policlinico Umberto I (IT), Ospedale Santa Maria Goretti (IT)
Openalex Percentile: Top 25%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.